Fulvestrant +/- Akt Inhibition in Advanced Aromatase Inhibitor Resistant Breast Cancer
Status: ACTIVE_NOT_RECRUITING
Study type: INTERVENTIONAL
Conditions: Estrogen Receptor Positive Breast Cancer
Interventions: DRUG: AZD5363|DRUG: Placebo|DRUG: Fulvestrant
Sponsor: Velindre NHS Trust
Collaborators: AstraZeneca|Cenduit LLC|Covance|Cardiff and Vale University Health Board